Kane Biotech (KNE) Stock Chart & Stock Price History C$0.04 +0.01 (+12.50%) As of 02:01 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock Kane Biotech Stock Price Performance The Kane Biotech (KNE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.86%, with a year-to-date return of -59.09%. In the past month, the stock has decreased 18.18%, reflecting recent market activity. As of the latest close, Kane Biotech traded at C$0.05 with a market cap of C$6.48 million and volume of 11,125 shares. Receive KNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.00%1 Month Performance-18.18%3 Month Performance-50.00%Year-To-Date Performance-59.09%1 Year Performance-67.86% KNE Stock Chart for Friday, July, 18, 2025 KNE Chart by TradingView Kane Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025C$0.05C$0.05C$0.05C$0.0511,125 shsC$6.48 million07/16/2025C$0.05C$0.05C$0.05C$0.0579,000 shsC$6.48 million07/15/2025C$0.04C$0.05+12.50%C$0.05C$0.04164,025 shsC$6.48 million07/14/2025C$0.05C$0.04-20.00%C$0.05C$0.04482,000 shsC$5.76 million07/11/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.20 million07/10/2025C$0.05C$0.05+11.11%C$0.05C$0.051,000 shsC$7.20 million07/09/2025C$0.05C$0.05C$0.05C$0.0527,222 shsC$6.48 million07/08/2025C$0.05C$0.05-10.00%C$0.06C$0.05191,000 shsC$6.48 million07/07/2025C$0.05C$0.05C$0.05C$0.0530,000 shsC$7.20 million07/04/2025C$0.05C$0.05C$0.06C$0.0587,000 shsC$7.20 million Get the Latest News and Ratings for KNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025C$0.06C$0.05-9.09%C$0.06C$0.0529,220 shsC$7.20 million07/02/2025C$0.05C$0.06+10.00%C$0.06C$0.061,100 shsC$7.92 million07/01/2025C$0.05C$0.05C$0.06C$0.0517,056 shsC$7.20 million06/30/2025C$0.06C$0.05-9.09%C$0.06C$0.0517,056 shsC$7.20 million06/27/2025C$0.05C$0.06+10.00%C$0.06C$0.0566,000 shsC$7.92 million06/26/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.20 million06/25/2025C$0.05C$0.05+11.11%C$0.05C$0.051,000 shsC$7.20 million06/24/2025C$0.05C$0.05-10.00%C$0.05C$0.05235,000 shsC$6.48 million06/23/2025C$0.06C$0.05-9.09%C$0.06C$0.0565,000 shsC$7.20 million06/20/2025C$0.06C$0.06C$0.06C$0.062,425 shsC$7.92 million06/19/2025C$0.06C$0.06C$0.06C$0.062,500 shsC$7.92 million06/18/2025C$0.06C$0.06C$0.06C$0.0665,600 shsC$7.92 million06/17/2025C$0.06C$0.06C$0.06C$0.0626,000 shsC$7.92 million Related Companies Devonian Health Group Stock Price Chart Hemostemix Stock Price Chart Sirona Biochem Stock Price Chart Innovotech Stock Price Chart Resverlogix Stock Price Chart BriaCell Therapeutics Stock Price Chart Quest PharmaTech Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Theratechnologies Stock Price Chart Oncolytics Biotech Stock Price Chart Receive KNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:KNE) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kane Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
